Entera Bio
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Entera Bio and other ETFs, options, and stocks.About ENTX
Entera Bio Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of orally delivered large molecule therapeutics. It s pipeline include PTH(1-34), GLP-1 and GLP-2.
CEOMiranda J. Toledano
CEOMiranda J. Toledano
Employees20
Employees20
HeadquartersJerusalem, Jerusalem
HeadquartersJerusalem, Jerusalem
Founded2009
Founded2009
Employees20
Employees20
ENTX Key Statistics
Market cap137.45M
Market cap137.45M
Price-Earnings ratio-11.68
Price-Earnings ratio-11.68
Dividend yield—
Dividend yield—
Average volume190.95K
Average volume190.95K
High today$3.15
High today$3.15
Low today$2.92
Low today$2.92
Open price$3.15
Open price$3.15
Volume89.85K
Volume89.85K
52 Week high$3.22
52 Week high$3.22
52 Week low$1.50
52 Week low$1.50
Stock Snapshot
Entera Bio(ENTX) stock is priced at $3.00, giving the company a market capitalization of 137.45M. It carries a P/E multiple of -11.68.
As of 2025-11-11, Entera Bio(ENTX) stock has fluctuated between $2.92 and $3.15. The current price stands at $3.00, placing the stock +2.7% above today's low and -4.8% off the high.
The Entera Bio(ENTX)'s current trading volume is 89.85K, compared to an average daily volume of 190.95K.
During the past year, Entera Bio(ENTX) stock moved between $1.50 at its lowest and $3.22 at its peak.
During the past year, Entera Bio(ENTX) stock moved between $1.50 at its lowest and $3.22 at its peak.
People also own
Based on the portfolios of people who own ENTX. This list is generated using Robinhood data, and it’s not a recommendation.